Viewing Study NCT00733668


Ignite Creation Date: 2025-12-24 @ 5:37 PM
Ignite Modification Date: 2025-12-26 @ 10:47 AM
Study NCT ID: NCT00733668
Status: COMPLETED
Last Update Posted: 2009-03-25
First Post: 2008-08-12
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Efficacy of SEROQUEL in Selective Serotonin Reuptake Inhibitors (SSRI)-Resistant Major Depressive Disorder
Sponsor: AstraZeneca
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: D1449C00009
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: None
Responsible Party Affiliation:
Old Name: An Matthys, MD, Therapeutic Area Leader CNS
Old Organization: AstraZeneca Pharmaceuticals

Collaborators